Our structural biology platform is equipped with state-of-the-art instrumentation for X-ray crystallography, including protein production, robotic nanoliter-scale crystallization screening, robotic optimization of conditions for crystal growth and crystallization drop imaging. For X-ray data collection we use MAX IV synchrotron radiation facility, which is located a couple of kilometres from our labs in Lund. Alternatively, we send the crystals to other European synchrotrons. We collect X-ray data approximately every second week.

For NMR spectroscopy we have access to high-quality, cutting-edge instrumentation. We provide de novo NMR protein structure determination, protein-ligand/protein-protein complex NMR structure determination as well as small molecule fragment library screening.

Each year our platform handles on average over 100 new contract research projects within the field of Structural Biology. We worked with nearly all large pharmaceutical companies and more than 100 biotech companies and academic groups. Currently we have deposited more than 500 disclosable PDB X-ray and NMR spectroscopy structures.

And probably the best testimonials anybody can get: we have contributed to more than 240 co-authored structural papers published in leading journals like Nature, Nature Commun., J Biol Chem, J. Synchrotron Rad., PNAS, J Med Chem, JACS, etc.

You may visit our learning center for an overview of the experimental technologies we use in protein crystallization and X-ray crystallography, NMR spectroscopy and drug discovery services.

To discuss your project, please, use the form below!